MARKET

LCTX

LCTX

Lineage Cell The
AMEX
1.540
0.000
0.00%
Opening 10:56 04/09 EDT
OPEN
1.540
PREV CLOSE
1.540
HIGH
1.560
LOW
1.535
VOLUME
85.27K
TURNOVER
--
52 WEEK HIGH
2.090
52 WEEK LOW
0.3651
MARKET CAP
383.59M
P/E (TTM)
-5.5777
1D
5D
1M
3M
1Y
5Y
1D
Lineage Cell Therapeutics management to meet with Craig-Hallum
TipRanks · 17h ago
Service Properties Trust, ConocoPhillips And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga · 3d ago
Weekly Report: what happened at LCTX last week (0330-0403)?
Weekly Report · 3d ago
Weekly Report: what happened at LCTX last week (0323-0327)?
Weekly Report · 03/30 09:47
Lineage Cell Therapeutics Is Maintained at Buy by B. Riley Securities
Dow Jones · 03/25 15:23
Lineage Cell Therapeutics Price Target Raised to $4.00/Share From $3.00 by B. Riley Securities
Dow Jones · 03/25 15:23
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 03/25 12:20
Lineage Cell Therapeutics price target raised to $4 from $3 at B. Riley
TipRanks · 03/25 12:16
More
About LCTX
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing cell replacement therapies to treat serious medical conditions. The Company programs are based on a cell-based technology platform, AlloSCOPE, which develops formulation, manufacturing, and delivery capabilities, and serves as the source of its pluripotent cell-based product candidates. Its pipeline includes OpRegen, an allogeneic retinal pigment epithelial (RPE) cell replacement therapy for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (dry-AMD); OPC1, an allogeneic oligodendrocyte progenitor cell therapy for the treatment of spinal cord injuries (SCI); ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant therapy for the treatment of auditory neuropathy; ILT1, an allogeneic cell transplant research initiative for the treatment of Type 1 Diabetes (T1D).

Webull offers Lineage Cell Therapeutics Inc stock information, including AMEX: LCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LCTX stock methods without spending real money on the virtual paper trading platform.